CJC-1295 No DAC 5 mg
Lyophilized CJC-1295 No DAC peptide (5 mg) supplied as a high-purity research compound suitable for laboratory investigations involving GHRH receptor interaction and pulsatile endocrine signaling studies.
€ 51.00
Description
CJC-1295 (Compound number 1295 developed by ConjuChem) without DAC (Drug Affinity Complex) is a synthetic peptide that belongs to the growth hormone releasing hormone (GHRH) analogues. It is designed to stimulate the release of growth hormone (GH) from the pituitary gland, which can contribute to various physiological effects such as tissue growth, cell reproduction and regeneration.
In research environments, CJC-1295 No DAC is studied for its interaction with GHRH receptors and its role in stimulating regulated growth hormone release mechanisms within neuroendocrine models. The peptide’s pharmacokinetic profile makes it suitable for investigations requiring precise timing of peptide activity and signaling response analysis.
The peptide is supplied as a lyophilized powder to preserve molecular stability and enable accurate reconstitution prior to laboratory application. Each batch is manufactured using advanced solid-phase peptide synthesis and undergoes strict analytical quality control to verify purity and molecular identity.
Features of CJC-1295 without DAC:
- Short half-life: Without the DAC component, this peptide has a shorter half-life, usually around 30 minutes. This means it is broken down and excreted from the body faster.
- Natural GH pulses: Due to its shorter duration of action, it stimulates a more natural, pulsatile release of growth hormone, similar to the body’s natural secretion patterns.
Mechanism of action:
CJC-1295 without DAC binds to GHRH receptors in the pituitary gland, leading to increased secretion of growth hormone. This may have potential benefits, such as:
- Improved muscle growth and recovery through increased protein synthesis.
- Faster fat burning through stimulation of lipolysis.
- Improved sleep quality. Growth hormone plays a role in the regulation of deep sleep stages.
This peptide is intended for use only in controlled scientific environments and by professionals familiar with proper peptide handling and laboratory standards.
Research Use Only Disclaimer
This product is sold strictly for laboratory research, analytical, and scientific purposes only. It is not intended for human consumption, veterinary use, diagnostic use, therapeutic application, or personal use of any kind. By purchasing this product, the customer confirms that the material will be handled only by qualified professionals in an appropriate research setting.
| Ampoule | 5 mg |
|---|---|
| Bac. Water | 2 ml |
| Dosage | 200 mcg |
| Units on a 1ml insulin syringe | 8U |
| Time of administration | PM |
| Frequency | 5 days on/2 days off |
| Duration | 8 weeks |
- Product Name: CJC-1295 No DAC
- Peptide Type: Synthetic GHRH analog
- Quantity: 5 mg per sterile vial
- Modification: Non-DAC (short-acting variant)
- Purity: ≥98% (HPLC verified)
- Appearance: White to off-white lyophilized powder
- Form: Freeze-dried peptide
- Manufacturing Method: Solid-phase peptide synthesis
- Quality Control: HPLC and Mass Spectrometry tested
- Reconstitution: Requires sterile solvent prior to laboratory use
- Storage Conditions:
- Short term: 2–8°C
- Long term: −20°C recommended
- Stability: Stable under recommended storage conditions
- Intended Use: Scientific laboratory research applications only




